Background: Alterations in peptide-MHC interactions with the T cell receptor (TCR) can lead to dramatically different T cell outcomes. Results: We have found that T cells activated by A9 signal via FcR␥ and Syk. Conclusion: By dissecting the molecular mechanism of A9-induced T cell signaling, we have defined a new alternate pathway. Significance: Understanding this pathway may be critical for the proper application of Syk inhibitors to RA therapies.